TSE:2395'
s OCF Margin % Range Over the Past 10 Years
Min: -4.93 Med: 19.6 Max: 33.54
Current: 25.6
During the past 13 years, the highest OCF Margin % of Shin Nippon Biomedical Laboratories was 33.54%. The lowest was -4.93%. And the median was 19.60%.
TSE:2395's OCF Margin % is ranked better than 85.78% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs TSE:2395: 25.60
Shin Nippon Biomedical Laboratories OCF Margin % Related Terms
Shin Nippon Biomedical Laboratories OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2395 vs TMO, DHR, IDXX: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shin Nippon Biomedical Laboratories OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Shin Nippon Biomedical Laboratories's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shin Nippon Biomedical Laboratories (TSE:2395) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shin Nippon Biomedical Laboratories and its competitors. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #29 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 14.2%.
Is Shin Nippon Biomedical Laboratories' OCF Margin % too high?
Shin Nippon Biomedical Laboratories' current OCF Margin % is 0.00%. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #29 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #29 out of 204 companies for OCF Margin %. This places Shin Nippon Biomedical Laboratories in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shin Nippon Biomedical Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shin Nippon Biomedical Laboratories's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories (TSE:2395) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,761.39, compared to a current price of 円1,089.00 — trading 38.2% below its estimated fair value. The current OCF Margin % is 0.00%. Shin Nippon Biomedical Laboratories' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (TSE:2395), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shin Nippon Biomedical Laboratories (TSE:2395) Overvalued in 2026?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued.
The current stock price of 円1,089.00 is trading 38.2% below its estimated GF Value™ of 円1,761.39.
GuruFocus considers Shin Nippon Biomedical Laboratories to be Possible Value Trap.
Key valuation signals for TSE:2395:
OCF Margin %: 0.00%
GF Value™: 円1,761.39 vs. price of 円1,089.00 (38.2% below fair value)
No single metric tells the full story. See the TSE:2395 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shin Nippon Biomedical Laboratories Business Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
69GF Score
Get the complete analysis for TSE:2395
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2395 has been successfully added to your 
